JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Search

Integra LifeSciences Holdings Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

10.82 -1.73

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

10.8

Max

11.11

Pagrindiniai rodikliai

By Trading Economics

Pajamos

479M

-5.4M

Pardavimai

-14M

402M

Pelno marža

-1.344

Darbuotojai

4,396

EBITDA

526M

54M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+17.33% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-02-24

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-386M

869M

Ankstesnė atidarymo kaina

12.55

Ankstesnė uždarymo kaina

10.82

Naujienos nuotaikos

By Acuity

78%

22%

324 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-05 23:57; UTC

Uždarbis

Naver Has Record Year Despite Weaker Final Quarter

2026-02-05 23:45; UTC

Karštos akcijos

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

2026-02-05 22:26; UTC

Uždarbis

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

2026-02-05 22:00; UTC

Uždarbis

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

2026-02-05 23:47; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-02-05 23:47; UTC

Rinkos pokalbiai

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

2026-02-05 23:43; UTC

Rinkos pokalbiai

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

2026-02-05 23:37; UTC

Rinkos pokalbiai

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

2026-02-05 23:20; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

2026-02-05 23:11; UTC

Rinkos pokalbiai

Amazon CEO Confident in Return on $200B Investment -- Market Talk

2026-02-05 23:09; UTC

Uždarbis

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

2026-02-05 23:08; UTC

Uždarbis

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

2026-02-05 23:07; UTC

Uždarbis

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

2026-02-05 23:03; UTC

Rinkos pokalbiai
Uždarbis

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

2026-02-05 23:03; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

2026-02-05 23:00; UTC

Uždarbis

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

2026-02-05 23:00; UTC

Uždarbis

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

2026-02-05 22:59; UTC

Uždarbis

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

2026-02-05 22:59; UTC

Uždarbis

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

2026-02-05 22:52; UTC

Uždarbis

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

2026-02-05 22:45; UTC

Uždarbis

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

2026-02-05 22:37; UTC

Rinkos pokalbiai

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

2026-02-05 22:11; UTC

Uždarbis

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

2026-02-05 22:03; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

2026-02-05 22:01; UTC

Uždarbis

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

2026-02-05 21:59; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

2026-02-05 21:51; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

2026-02-05 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Basic Materials Roundup: Market Talk

2026-02-05 21:49; UTC

Uždarbis

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

2026-02-05 21:45; UTC

Uždarbis

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Akcijų palyginimas

Kainos pokytis

Integra LifeSciences Holdings Corp Prognozė

Kainos tikslas

By TipRanks

17.33% į viršų

12 mėnesių prognozė

Vidutinis 13 USD  17.33%

Aukščiausias 13 USD

Žemiausias 13 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Integra LifeSciences Holdings Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

3 ratings

0

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

12.75 / 16.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

324 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat